Study to Evaluate Vibegron on Patient Treatment Satisfaction Quality of Life and Healthcare Resource Utilization in Patients with Overactive Bladder

Age
18 years - 99 years
Gender
All
participants needed
20
Location
1
Find a site

Brief description of study

The purpose of this study is to understand: • If you’re satisfied using GEMTESA ® (Vibegron) • What side effects (if any) you may experience using GEMTESA ® (Vibegron) • How GEMTESA ® (Vibegron) impacts your quality of life, • If you need any additional treatment for Overactive Bladder (OAB) besides GEMTESA® (Vibegron). . Participation in the study is expected to last up to 12 months (1 year) but can be extended to 24 months (2 years). Compensation maximum $200.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Overactive Bladder
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 851067

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center